Search

Your search keyword '"Schepmoes, Athena A."' showing total 262 results

Search Constraints

Start Over You searched for: Author "Schepmoes, Athena A." Remove constraint Author: "Schepmoes, Athena A."
262 results on '"Schepmoes, Athena A."'

Search Results

1. Viral afterlife: SARS-CoV-2 as a reservoir of immunomimetic peptides that reassemble into proinflammatory supramolecular complexes.

2. Multi-scale signaling and tumor evolution in high-grade gliomas

4. Proteogenomic insights suggest druggable pathways in endometrial carcinoma

5. Plasma protein biomarkers predict the development of persistent autoantibodies and type 1 diabetes 6 months prior to the onset of autoimmunity

7. Multi-omics of NET formation and correlations with CNDP1, PSPB, and L-cystine levels in severe and mild COVID-19 infections

9. Apolipoprotein C3 and circulating mediators of preadipocyte proliferation in states of lipodystrophy

10. Interlaboratory Comparison of Antibody-Free LC-MS/MS Measurements of C-peptide and Insulin

12. Proteogenomic Characterization of Ovarian HGSC Implicates Mitotic Kinases, Replication Stress in Observed Chromosomal Instability

13. Integrated Omics Analysis of Pathogenic Host Responses during Pandemic H1N1 Influenza Virus Infection: The Crucial Role of Lipid Metabolism

14. Decrease in multiple complement proteins associated with development of islet autoimmunity and type 1 diabetes

16. Viral afterlife: SARS-CoV-2 as a reservoir of immunomimetic peptides that reassemble into proinflammatory supramolecular complexes.

18. Validation of a Proteomic Signature of Lung Cancer Risk from Bronchial Specimens of Risk-Stratified Individuals

19. Proteogenomic insights suggest druggable pathways in endometrial carcinoma

20. Decrease in multiple complement protein levels is associated with the development of islet autoimmunity and type 1 diabetes

21. Preconditioning in the Rhesus Macaque Induces a Proteomic Signature Following Cerebral Ischemia that Is Associated with Neuroprotection

23. Insights from a workplace SARS-CoV-2 specimen collection program, with genomes placed into global sequence phylogeny

24. Plasma protein biomarkers predict both the development of persistent autoantibodies and type 1 diabetes 6 months prior to the onset of autoimmunity: the TEDDY Study

26. Multi-omics Characterization of Neutrophil Extracellular Trap Formation in Severe and Mild COVID-19 Infections

30. Free 25-Hydroxyvitamin D: Impact of Vitamin D Binding Protein Assays on Racial-Genotypic Associations

32. The AML microenvironment catalyzes a stepwise evolution to gilteritinib resistance

33. Antibody-independent targeted quantification of TMPRSS2-ERG fusion protein products in prostate cancer

35. The AML Microenvironment Catalyzes a Step-Wise Evolution to Gilteritinib Resistance

36. A comprehensive collection of systems biology data characterizing the host response to viral infection

37. Improved methods for the enrichment and analysis of glycated peptides

38. Detection of Head and Neck Cancer Based on Longitudinal Changes in Serum Protein Abundance

39. Proteomic Tissue-Based Classifier for Early Prediction of Prostate Cancer Progression

42. Abstract 440: Use of longitudinal samples from the DOD serum repository to identify candidate biomarkers for HNSCC

43. Abstract 3165: Identification of candidate biomarkers for aggressive prostate cancer using targeted proteomics and FFPE tissue samples with outcomes data

44. Preconditioning in the Rhesus Macaque Induces a Proteomic Signature Following Cerebral Ischemia that Is Associated with Neuroprotection

45. Evaluation of SRM-, PRM- and DIA-based Targeted Quantification (ASMS 2017)

46. Antibody-Independent, Deep-Dive Targeted Quantification of Proteins at 10 pg/mL Levels in Non-Depleted Human Serum/Plasma (ASMS 2016)

47. MOESM5 of Quantification of mutant SPOP proteins in prostate cancer using mass spectrometry-based targeted proteomics

48. Evaluation of SRM-, PRM- and DIA-based Targeted Quantification

49. Verification of prostate cancer genomics biomarker candidates at protein level using SRM-MS (ASMS 2017)

50. Improved LC−MS/MS Spectral Counting Statistics by Recovering Low-Scoring Spectra Matched to Confidently Identified Peptide Sequences

Catalog

Books, media, physical & digital resources